Transversus Abdominis Plane Block for Postoperative Analgesia in Living Donor Hepatectomy
Acute Pain

About this trial
This is an interventional treatment trial for Acute Pain focused on measuring transversus abdominis plane block, living liver transplantation, postoperative analgesia
Eligibility Criteria
Inclusion Criteria:
- Liver transplantation donors
Exclusion Criteria:
- Patients with a history of allergy to the drugs used in the study protocol, coagulation pathology, opioid tolerance
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
transversus abdominis plane block
nonblocked
Patients who received a tranversus abdominis plane block with ultrasound after standard general anesthesia represented Group 1. The tranversus abdominis plane block was performed bilaterally by obtaining an image with real time ultrasound guidance with a 6-13 MHz linear probe. The block was placed with a 22 G 80 mm needle while obtaining real-time images via an in-plane technique. Two 20 mL syringes were prepared after preparing a local anesthetic concentration of 1.5 mg/kg of 0.5% bupivacaine to 40 mL with saline. These were administered to the left and right abdominal walls. Postoperative analgesia was administered through a morphine the patient-controlled analgesia device.
Patients who received standard general anesthesia alone made up Group 2. Postoperative analgesia was administered through a morphine the patient-controlled analgesia device.